Related Experiment Videos
Serum alpha-fetoprotein in chronic liver disease
Acta Medica Hungarica
|January 1, 1983
Summary
Serum alpha-fetoprotein (AFP) levels are elevated in chronic liver disease, with the highest concentrations indicating hepatocellular carcinoma. AFP measurement aids in diagnosing liver cancer and monitoring other liver conditions.
Area of Science:
- Hepatology
- Oncology
- Biochemistry
Background:
- Alpha-fetoprotein (AFP) is a protein produced during fetal development.
- Elevated AFP levels are associated with certain liver conditions.
Purpose of the Study:
- To investigate serum AFP levels in patients with chronic liver disease.
- To assess the diagnostic utility of AFP in hepatocellular carcinoma (HCC).
Main Methods:
- Radioimmunoassay (RIA) was used to measure serum AFP levels.
- Study included 20 normal subjects and 118 patients with chronic liver disease.
Main Results:
- Significantly higher AFP concentrations were observed in patients with chronic liver disease compared to controls.
- The highest AFP levels were detected in patients with hepatocellular carcinoma.
- Elevated AFP levels were also noted in other liver disease groups, attributed to liver regeneration and alcohol's effect in fatty degeneration.
Conclusions:
- Serum AFP estimation is crucial for diagnosing hepatocellular carcinoma and monitoring its treatment.
- AFP levels are valuable for assessing activity and regeneration in other chronic liver diseases.
- Countercurrent electrophoresis is unreliable for AFP measurement.